臨床試験支援サービス市場規模、シェア、成長分析：サービス別、フェーズ別、試験デザイン別、適応症別、スポンサー別、地域別 - 産業予測 2025～2032年

臨床試験支援サービス 2023年の市場規模は230億米ドルで、2024年の248億4,000万米ドルから2032年には459億8,000万米ドルに拡大し、予測期間（2025-2032年）のCAGRは8.0％で成長する見通しです。

臨床試験業界は、特にパンデミック以降、臨床試験、アッセイデザイン、サポートサービスに重点を置き、著しい進化を遂げてきました。研究用医薬品の確保・保管、治験施設の安全確保、薬剤投与量の計算、キットの管理など、不可欠な業務がこの領域で重要な役割を果たしています。特に2021年にCOVID-19ワクチンが開発された後、多くの延期された臨床試験が復活したことで、新興国市場で増加する慢性疾患、感染症、熱帯病に対処するための革新的な医薬品の緊急ニーズも浮き彫りになっています。さらに、バーチャル臨床試験へのシフトが臨床試験支援サービスの収益成長の主要な推進力として浮上しており、研究会社は臨床調査方法の効率性を高めるためにバーチャル技術の採用を増やしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

臨床試験支援サービス市場規模：サービス別& CAGR（2025-2032）

• 市場概要
• 管理スタッフ
• 臨床試験施設管理
  • 患者募集および登録サービス
  • 患者募集管理
  • 患者の維持
• データ管理
• 機関審査委員会

臨床試験支援サービス市場規模：フェーズ別& CAGR（2025-2032）

• 市場概要
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

臨床試験支援サービス市場規模：試験デザイン別& CAGR（2025-2032）

• 市場概要
• 拡張アクセス
• 介入的
• 観察的

臨床試験支援サービス市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 自己免疫または炎症
• 心臓血管
• 糖尿病
• 腫瘍学

臨床試験支援サービス市場規模：スポンサー別& CAGR（2025-2032）

• 市場概要
• 医療機器
• 医薬品・バイオ医薬品

臨床試験支援サービス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Charles River Laboratories International, Inc.（USA）
• Syneos Health, Inc.（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Wuxi AppTec Co., Ltd.（China）
• Eurofins Scientific（Luxembourg）
• ACM Global Laboratories（USA）
• Clinipace Worldwide（USA）
• Worldwide Clinical Trials（USA）
• Premier Research（USA）
• PSI CRO AG（Switzerland）
• Novotech（Australia）
• Velocity Clinical Research（USA）
• Fortrea（USA）
• CTI Clinical Trial and Consulting Services（USA）

結論と提言

Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)

• Market Overview
• Administrative Staff
• Clinical Trial Site Management
  • Patient Recruitment & Registry Services
  • Patient Recruitment Management
  • Patient Retention
• Data Management
• Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)

• Market Overview
• Expanded Access
• Interventional
• Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Autoimmune or Inflammation
• Cardiovascular
• Diabetes
• Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)

• Market Overview
• Medical Devices
• Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2025-2032)

• North America (Service, Phase, Study Design, Indication, Sponsor)
  • US
  • Canada
• Europe (Service, Phase, Study Design, Indication, Sponsor)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Study Design, Indication, Sponsor)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velocity Clinical Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations